Remission

VIENNA — In a Healio video exclusive, Maria T. Abreu, MD, reported mirikizumab induced “rapid control” of bowel movement urgency and fatigue among patients with mild to moderate ulcerative colitis.

After previously discontinuing infliximab, 35% of patients with Crohn’s disease achieved remission at 26 weeks with drug retreatment, according to a study published in The American Journal of Gastroenterology.

Patients with systemic lupus erythematosus who achieve remission, regardless of treatment status, or low disease activity are less likely to accrue as much systematic damage as those who do not reach treatment goals, according to data.

Endoscopic transsphenoidal surgery has the best remission rates and fewest postoperative complications for adults with acromegaly, according to findings from a systematic review.

Children aged 1 to 11 years with eosinophilic esophagitis safely achieved histologic disease remission after 16 weeks of treatment with the fully human monoclonal antibody dupilumab, according to the results of a phase 3 trial.

In youth with Tourette syndrome and other persistent tic disorders, treatment with behavioral therapy was linked with symptom remission and a reduction in tic severity, according to a new study.

For decades, clinicians and researchers have recognized that some people with type 2 diabetes of short duration who adhere to intensive glucose-lowering therapy can achieve normal blood glucose levels and discontinue treatment.

The 2022 EULAR recommendations for the management of rheumatoid arthritis are largely similar to the 2019 updates, with one point of emphasis being the importance of rapid glucocorticoid reduction and discontinuation.

SAN DIEGO — Patients with ulcerative colitis who responded to mirikizumab at 12 weeks achieved and maintained clinical remission and improved bowel urgency severity at 1 year in the phase 3 LUCENT-2 study.

SAN DIEGO — In a Healio video exclusive, Marla C. Dubinsky, MD, discusses results from the ELEVATE UC trials, in which once daily etrasimod induced clinical remission in patients with ulcerative colitis.